Study on the Compatibility Rule of Huanglian Jiedu Tang Based on Metabonomics
|更新时间:2024-01-04
|
Study on the Compatibility Rule of Huanglian Jiedu Tang Based on Metabonomics
Chinese Journal of Experimental Traditional Medical FormulaeVol. 18, Issue 13, Pages: 146-152(2012)
作者机构:
作者简介:
基金信息:
DOI:
CLC:
Published:2012
稿件说明:
移动端阅览
LIU Chang-feng, CHEN Ping-ping, LIU Shu-min, et al. Study on the Compatibility Rule of Huanglian Jiedu Tang Based on Metabonomics[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(13): 146-152.
DOI:
LIU Chang-feng, CHEN Ping-ping, LIU Shu-min, et al. Study on the Compatibility Rule of Huanglian Jiedu Tang Based on Metabonomics[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(13): 146-152.DOI:
Study on the Compatibility Rule of Huanglian Jiedu Tang Based on Metabonomics
Objective: To study the compatibility rule of Huanglian Jiedu Tang based on metabonomics. Method: Fifty-four male Wistar rats were randomly divided into six groups including control group
model group
Huanglian group
Huanglian-Huangqin group
Huanglian-Huangqin-Huangbai group and Huanglian Jiedu Tang group. The treatment groups were orally administrated with corresponding drug at a dose of 7.2
12
16.8
24 g crude drug·kg-1
respectively. Thirty minute later
the model group and treatment groups were injected with a DNP solution (sc
25 mg·kg-1). The urine of rats was collected during period of 0-1
1-3
3-5
5-7
7-13
13-22 h
respectively. The urine samples were analyzed by UPLC-TOF/MS and the urine mass spectrometry data were processed by MarkerLynx XS software and analyzed further by principal component analysis (PCA) and orthogonal partial least squares-discriminant analysis (OPLS-DA). Result: In the score plot
the Huanglian group was mixed with model group
the Huanglian-Huangqin group was close to model and farther away from the control group
the Huanglian-huangqin-huangbai group
the model and conrtol group were distributed in 3 clusters in the principal components analysis diagram without overlap
and closer to the control group
the Huanglian Jiedu Tang group
the model group and control group were distributed in 3 clusters in the principal components analysis diagram without overlap
and their distances were identical; meanwhile
33
15
36
40 biomarkers were respectively interfered by the Huanglian
Huanglian-Huangqin
Huanglian-Huangqin-Huangbai and Huanglian Jiedu Tang groups. After comprehensively evaluating the intervention effect of treatment groups according to the overall metabolism of fever syndrome and endogenous biomarker variations
we found that the order of effect strength was Huanglian Jiedu Tang
Huanglian-Huangqin-Huangbai
Huanglian
Huanglian-Huangqin. Conclusion: Huanglian as the monarch herb play a major pharmacological action; Huangbai and Zhizi as the assistant and guide herbs also play their respective roles; however Huangqin as the minister herb is to be discussed.